BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28348113)

  • 1. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.
    Ruhs S; Nolze A; Hübschmann R; Grossmann C
    J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of rapid aldosterone signaling.
    Grossmann C; Gekle M
    Mol Cell Endocrinol; 2009 Sep; 308(1-2):53-62. PubMed ID: 19549592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.
    Meinel S; Gekle M; Grossmann C
    Steroids; 2014 Dec; 91():3-10. PubMed ID: 24928729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.
    Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W
    Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenotropic aldosterone effects and the EGFR: interaction and biological relevance.
    Grossmann C; Gekle M
    Steroids; 2008 Oct; 73(9-10):973-8. PubMed ID: 18249428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Genomic Effects of Aldosterone.
    Mihailidou AS; Tzakos AG; Ashton AW
    Vitam Horm; 2019; 109():133-149. PubMed ID: 30678853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EF domains are sufficient for nongenomic mineralocorticoid receptor actions.
    Grossmann C; Freudinger R; Mildenberger S; Husse B; Gekle M
    J Biol Chem; 2008 Mar; 283(11):7109-16. PubMed ID: 18184651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
    Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and rapid effects of aldosterone: what we know and do not know thus far.
    Hermidorff MM; de Assis LV; Isoldi MC
    Heart Fail Rev; 2017 Jan; 22(1):65-89. PubMed ID: 27942913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid mineralocorticoid receptor trafficking.
    Gekle M; Bretschneider M; Meinel S; Ruhs S; Grossmann C
    Steroids; 2014 Mar; 81():103-8. PubMed ID: 24252381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nongenomic actions of aldosterone.
    Funder JW
    Endocr Rev; 2005 May; 26(3):313-21. PubMed ID: 15814845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor actions in cardiovascular development and disease.
    Young MJ; Clyne CD
    Essays Biochem; 2021 Dec; 65(6):901-911. PubMed ID: 34414409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.
    Ashton AW; Le TY; Gomez-Sanchez CE; Morel-Kopp MC; McWhinney B; Hudson A; Mihailidou AS
    Mol Endocrinol; 2015 Aug; 29(8):1144-55. PubMed ID: 26121234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenomic actions of aldosterone: physiological or pathophysiological role?
    Mihailidou AS
    Steroids; 2006 Apr; 71(4):277-80. PubMed ID: 16280143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response.
    Le Moëllic C; Ouvrard-Pascaud A; Capurro C; Cluzeaud F; Fay M; Jaisser F; Farman N; Blot-Chabaud M
    J Am Soc Nephrol; 2004 May; 15(5):1145-60. PubMed ID: 15100355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-Mediated Renal Sodium Transport Requires Intact Mineralocorticoid Receptor DNA-Binding in the Mouse.
    Cole TJ; Terella L; Morgan J; Alexiadis M; Yao YZ; Enriori P; Young MJ; Fuller PJ
    Endocrinology; 2015 Aug; 156(8):2958-68. PubMed ID: 26066075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions.
    Grossmann C; Benesic A; Krug AW; Freudinger R; Mildenberger S; Gassner B; Gekle M
    Mol Endocrinol; 2005 Jul; 19(7):1697-710. PubMed ID: 15761031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models.
    Le Menuet D; Viengchareun S; Muffat-Joly M; Zennaro MC; Lombès M
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):127-36. PubMed ID: 15134811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrarenal effects of aldosterone.
    Nguyen Dinh Cat A; Jaisser F
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):147-56. PubMed ID: 22240440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.